Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Physio > Regulation Of Vascular Smooth Muscle > Flashcards

Regulation Of Vascular Smooth Muscle Flashcards

1
Q

Local control of blood flow to vascular bed controls what aspects of tissue needs?

A

. Delivery of O2
. Delivery of nutrients to tissue
. Removal of CO2 from tissues
. Removal of H from tissues
. Maintenance of proper concentrations of other ions in the tissues
. Transport of hormones and other substance to tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The largest pressure drop in circulatory system occurs along ____

A

Small arterioles and precapillary sphincters

. Due to large number of capillary vessels arranged in parallel dec. their resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Functions of local blow flow control mechanisms

A

. Maintaining tissue blood flow at constant level

. Match blood flow to metabolic needs of tissue (inc. metabolism, inc. blood flow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Autoregulation

A

. Intrinsic tendency of organ to main constant blood flow despite changes in arterial perfusion pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Autoregulation in local blood flow when arterial pressure inc.

A

. Passive, rapid inc. in blood flow followed by gradual decline towards initial value
. Blood flow dec. due to automatic change in resistance (vasoconstriction)
. Results in autoregulation of vascular bed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tissues that have poor autoregulation

A

. Skin

. Lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tissues with good autoregulation

A

. Brain

. Kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 major mechanisms responsible for dynamic autoregulation

A

. Myotonic and metabolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Myogenic response in autoregulation

A

. Smooth muscle-active response to acute changes in transmural pressure
. If pressure dec., smooth mm. Relax,opposite if pressure inc.
. Results in gradual return of blood flow at initial level
. Stretch-sensitive ion channels involved
. Dec. in perfusion pressure causes passive dec. in vessel diameter (passive dec. in wall tension) and blood flow -> smooth mm. Relaxes -> diameter inc. -> resistance dec. -> blood flow returns to initial level
. Opposite for inc. in perfusion pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metabolic regulation of blood flow

A

. Passive changes in blood flow caused by change in perfusion pressure affect local conc. Of vasodilator metabolites
. Present at any given cell activity level, but influence depends on conc.
. If pressure inc., flow inc. -> inc. flow washes out the local conc. Of metabolites and smooth mm. Constricts -> returns to initial blood flow
. Opposite for dec. in pressure
. Tissue metabolism is not changing under these conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Blood flow in active hyperemia

A

.blood flow of organ locally adjusted to meet the inc. metabolic demands of tissue
. As rate of metabolism inc., blood flow inc. due to inc. production of vasodilator metabolites
. Important mechanisms for raising blood flow in response to skeletal mm. Activity and inc. work in cardiac, GI, and cerebral tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Blood flow in reactive hyperemia

A

. In response to ischemia, blood flow inc. above initial levels after release of occlusion
. Accumulation of metabolites during ischemia drives dilation of vessels
. Hyperemia gradually resolves as blood flow washes out metabolites accumulated
. Duration and magnitude of hyperemia is proportional to time of ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Local metabolic factors that are responsible for active vasodilation

A 
. K 
. CO2
. local hypoxia 
. H+
. Phosphate ions 
. PGI2
. Adenine nucleotides 
. Adenosine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Adenine nucleotides

A 
. Have a receptor on endothelium 
. Inc. PGI2
. Inc. endothelial derived hyperpolarizing factor (EDHF)
. Inc. NO production 
. Promote relaxation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adenosine

A

. Purine nucleoside released from cells when metabolism inc. or hypoxia
. Causes vasodilation by acting directly on vascular smooth mm. To inc. cAMP production (adenosine A2 receptor) and/or stimulating NO release of NO from vascular endothelial cells (adenosine A1 receptor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sympathetic control of vascular tone

A

. Controls vascular resistance in most vascular beds
. Precapillary resistance vessels innervated via postganglionic nn. That use NE
. Fibers tonically active in most beds so withdrawal of sympathetic causes passive vasodilation
. Contraction is mediated via a1 adrenergic receptors on smooth mm.
. Constriction may be attenuated by local vasodilator metabolites or mediators

17
Q

Parasympathetic control of vascular tone

A

. Arterioles in mist vascular beds don’t have PNS innervation
. Exception: external genitalia, cerebral, and coronary tissues
. Vasodilation mediated via muscarinic receptors that trigger NO generation
. Vasodilation of these small vascular beds does not directly affect systemic vascular resistance

18
Q

Endothelial based control of smooth muscle tone

A

. Endothelium itself can release vasoconstrictors and vasodilators in response to mechanical forces, local metabolites, NTs, hormones, and peptides
. Flow induced arterial vasodilation: endothelial-based dilation mediated by NO causing acute inc. in blood flow

19
Q

Vasodilator substances generated in endothelial cells that control vascular tone

A

. NO released in response to shear stress, NTs like ACh, bradykinin, histamine, serotonin, and ATP/ADP ratio
. All factories inc. intracellular Ca that activates NO synthase (NOS) to generate NO from Arg

20
Q

NO pathway

A

. Diffuses into vascular smooth mm. -> activates guanylyl cyclase-> inc. intracellular cGMP conc. Promoting relaxation of smooth mm.

21
Q

Phosphodiesterase inhibitor

A

. Phosphodiesterase breaks down cAMP and cGMP
. Inhibitor prevents this causing continued vasodilation
. Viagra in example (ED and pulmonary hypertension treatment)

22
Q

Endothelium-derived hyperpolarizing Factor

A

. Hyperpolarizing smooth mm. Causing relaxation
. Triggers K efflux from smooth muscle cells
. Interstitial K is known to open certain K channels
. Other putative factors include H2O2 and short-lived products of arachidonic acid cascade (EETs)

23
Q

Prostacyclin (PGI2)

A

. Family of substances that are generated from arachidonic acid in cell membranes using the COX pathway
. Inhibition of COX enzyme is main pharmacological effect of NSAIDs
. Some are vasodilatory and vasoconstrictors
. PG family and related compounds are involved in inflammation
. PGI2 released from endothelial cells and other tissues
. Released by many of the same factors that cause NO release
. Acts at a receptor vascular smooth m. To inc. cAMP promoting relaxation
. Inhibits platelet aggregation

24
Q

Histamine

A

. Biologically active amine
. Released from mast cells
. Relaxes arterioles and precapillary sphincters and inc. capillary permeability (Kf)
. Promotes relaxation by acting on H2 receptors on vascular smooth m. To inc. cAMP promoting relaxation OR
. Acting on H1 receptors on endothelial cells to promote NO production and stimulate PGI2 release from endothelium

25
Q

Serotonin

A

. Biologically active amine
. Released from platelets
. Vasodilator responsemediated by endothelial release of NO
. In absence of intact endothelium, it directly constricts vascular smooth mm. Of arterioles
. Also constricts postcapillary venules

26
Q

Bradykinin

A

, local peptide
. Arteriolar vasodilation mediated by endothelial release of NO, PGI2, and EDRF
. Caused inc. venule permeability leading to inc. filtration

27
Q

Atrial natriuretic peptide (ANP)/B-type natriuretic peptide (BNP)

A

. Family of peptide hormones synthesized and stored in atrial (ANP) or ventricular (BNP) myocytes
. Released w/ atrial stretch (ANP) or ventricular pressure/volume overload (BNP)
. Vasodilator action results form stimulation of guanylyl cyclase activity in vascular smooth m. (NPR-A and B receptors)
. ANP acts directly on smooth mm. To promote relaxation
. Promotes natriuresis and diuresis and inhibits myocardial hypertrophy and fibrosis
. Inhibits renin release and aldosterone synthesis and release

28
Q

Neutral endopeptidase (NEP)

A

. Neprilysin
. Breaks down natriuretic peptides
. NEP inhibition is potential therapeutic strategy in chronic HF
. Catalyzes the degradation of angiotensin II ad bradykinin

29
Q

Endothelin

A

Family of related peptides
. Released in response to stretching of blood vessels and other hormones (catecholamiens/AII)
. Important under pathophysiologic conditions
. Vasoconstriction mediated by ETa receptors on vascular smooth mm. Causing inc. Ca release from SR
. Vasodilation occurs through ETb receptors and buffers vasoconstriction produced by ETA receptors
. Net effect is vasoconstriction

30
Q

Prostaglandins

A

Arachidonic acid derivatives generated in endothelial cells
. PGH2 may act directly as a vasoconstrictor or be source of synthesis of TxA2
. Synthesis of vasoconstrictors vs vasodilators from PGH2 depends on secondary enzymes
. PGF2alpha: vasoconstrictor in circulatory beds and causes contraction of uterine smooth muscle
. TXA2: structurally related to PG, produced by aggregating platelets, act directly on smooth m. To cause vasoconstriction

31
Q

Epinephrine

A

. Released from adrenal medulla from SNS activation
. Contraction via alpha1/2 adrenergic receptors on vascular smooth mm. Of resistance vessels and veins
. Relaxation of beta2 adrenergic receptors on vascular smooth m. Of resistance vessels
. Net effect dependent on conc. In plasma, density of adrenergic receptors, and affinity of E to adrenergic receptors in that tissue
. Most tissues vasocontriction
. Skeletal mm. Have vasodilation due to higher conc. Of beta2 receptors and higher E affinity

32
Q

Angiotensin II

A

. Peptide hormone produced from sequential hydrolysis of precursor angiotensinogen
. Released in response to low bp and low blood volume
. Potent vasoconstrictor
. Acts directly on vascular smooth m. Of resistance vessels and endothelium by AT1 receptor

33
Q

Vasopressin

A

. Peptide hormone released from post. Pituitary in response to rising plasma osmolality or falling bp or AII
. Potent vasoconstrictor
. Acts directly on vascular smooth m. (V1 receptors/V1R) of resistance vessels

Physio (62 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions